Dear Sir I read the summary of your article and I find it very interesting, but I have some questions I'd like to share with you.
What is the mechanism of action of a peptide to inhibit the JNK signaling pathway?
How does a peptide, injected at subconjunctival level, can produce a decrease in intraocular inflammation?
Sincerely
J.M. Lou-Bonafonte
Article Subconjunctival Injection of XG-102, a JNK Inhibitor Peptide...